Cytokinetics | CYTK - Sales Revenues


Cytokinetics reported $28.6M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Acadia Pharmaceuticals USD 307.96M 39.9M Jun/2026
Amgen USD 10.1B 1.48B Jun/2026
Arca Biopharma 0 0 Mar/2025
Bayer EUR 10.87B 2.54B Jun/2026
Biogen USD 2.8B 60M Sep/2026
Brainstorm Cell Therapeutics 0 0 Mar/2025
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
Capricor Therapeutics USD 11.13M 8.87M Dec/2024
Cytokinetics USD 28.6M 9.25M Jun/2026
Eisai JPY 234.33B 28.9B Jun/2026
Eli Lilly USD 22.97B 3.17B Jun/2026
Exelixis USD 628.69M 17.89M Jun/2026
Geron USD 57.48M 5.64M Jun/2026
Halozyme Therapeutics USD 481M 104M Jun/2026
Ionis Pharmaceuticals USD 268M 22M Jun/2026
Ligand Pharmaceuticals USD 83.7M 31.98M Jun/2026
Merck USD 16.6B 310M Jun/2026
Novartis USD 14.52B 112M Sep/2026
Pfizer USD 15.03B 530M Jun/2026
Regeneron Pharmaceuticals USD 4.29B 690M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 11.95B 710M Jun/2026